Searchable abstracts of presentations at key conferences in endocrinology

ea0099ep481 | Endocrine-Related Cancer | ECE2024

Renal metastasis from papillary thyroid carcinoma: about a case

Bouchenna Amira , Meriem Bansaleh

Introduction: Papillary thyroid cancer is a cancer with a good prognosis and slow progression. Only 2 to 10% of distant metastases, the most frequent at the pulmonary level, cranial metastases represent 2.5 to 5.8% of cases. Renal metastases are extremely rare. We report a case.Observation: 74-year-old patient, without suggesting, presents papillary thyroid carcinoma in its trabecular variant classified pT2NxM1, discovered following a left iliac metastas...

ea0090p256 | Thyroid | ECE2023

Non-secreting pheochromocytoma or adrenal metastasis of medullary thyroid cancer? When the differential diagnosis is difficult

Bouchenna Amira , Kablia Samia Ould

Introduction: Medullary thyroid cancer (MTC) accounts for 5-10% of thyroid cancers.25% of cases may be hereditary related to multiple endocrine neoplasia type 2 A (MEN2A) and associated with pheochromocytoma. Metastases from CMT are preferentially lymph node chains. However, other localizations are possible such as adrenal metastases which remain exceptional.Observation: We report the case of a 35-year-old patient with CMT for which he underwent thyroide...

ea0090p802 | Thyroid | ECE2023

Graves’ disease associated with thymic hyperplasia: about a case

Bouchenna Amira , Kablia Samia Ould

Introduction: The association between Graves’ disease and thymic hyperplasia was first described in 1912. Hundreds of cases have since been described. This rare association doesn’t seem fortuitous. We report a case.Observation: A 30-year-old patient with no particular personal history who consults following the onset of dyspnea with chest tightness. A CT scan of the chest revealed thymic hyperplasia. The preoperative assessment found an hyperth...

ea0099ep494 | Diabetes, Obesity, Metabolism and Nutrition | ECE2024

Dazzeling evolution with unusual metastases of a medullary thyroid carcinoma: about a case

Bouchenna Amira , Katia Benabdelatif , meriem Bensaleh

Introduction: At the time of diagnosis of medullary thyroid carcinoma (MTC) 10 to 15% of patients have distant metastases, 25% of them develop them over a longer or shorter period of time. The usual metastases concern cervical lymphadenopathy, bone, lung and liver. There are also unusual secondary localisations. We report a case.Observation: A 56-year-old patient who consulted a year after apparition of cervical lymphadenopathy, whose fine needle aspirat...

ea0099ep377 | Endocrine-Related Cancer | ECE2024

Acromegaly associated with papillary thyroid carcinoma: report of a case

Bouchenna Amira , Aicha Lachkhem , Meriem Bensaleh

Introduction: The association between acromegaly and neoplasia is rare but described, particularly colorectal and thyroid cancers, especially since the disease is not controlled.Observation: We report the case of a 44-year-old patient, hypertensive, diabetic, followed for acromegaly clinically retained in the face of dysmorphic syndrome, an IGF1 at 3.5 times normal on a pituitary macroadenoma of 9.9x13x9.3. The assessment of the impact of this acromegaly...

ea0099ep494 | Endocrine-Related Cancer | ECE2024

Dazzeling evolution with unusual metastases of a medullary thyroid carcinoma: about a case

Bouchenna Amira , Katia Benabdelatif , meriem Bensaleh

Introduction: At the time of diagnosis of medullary thyroid carcinoma (MTC) 10 to 15% of patients have distant metastases, 25% of them develop them over a longer or shorter period of time. The usual metastases concern cervical lymphadenopathy, bone, lung and liver. There are also unusual secondary localisations. We report a case.Observation: A 56-year-old patient who consulted a year after apparition of cervical lymphadenopathy, whose fine needle aspirat...

ea0081ep622 | Endocrine-Related Cancer | ECE2022

Refractory papillary thyroid carcinoma treated with sorafenib: an Algerian experience

Bouchenna Amira , Tibouk Abdelghani , Brahim Ghennam , Samia Ould Kablia

Introduction: 5-10% of papillary thyroid carcinoma develop metastatic disease, of which about 60-70% will become refractory to radioactive iodine. Significant negative impact on the prognosis and an average life expectancy of 3 to 5 years.Material and method: Since 2018, patients with refractory thyroid carcinoma and considered to be progressive according to the RECIST criteria have been treated with anti tyrosine Kinase type sorafenib.<p class="abst...

ea0081ep1146 | Thyroid | ECE2022

Papillary carcinoma of the thyroid associated with Marine-Lenarth syndrome: about a case

Bouchenna Amira , Tibouk Abdelghani , Brahim Ghennam , Samia Ould Kablia

Introduction: The Marine-Lenhart syndrome (MLS) is commonly defined as a combination of Graves’ disease and autonomous functioning thyroid nodule (s). the risk of malignancy of these nodules is less than 1% We report a case.Observation: 27-year-old patient, hospitalized for treatment of a basal disease, cervical ultrasound found a 1.5 cm lower left lobe thyroid nodule classified eutirads 4. the sintigraphy found an aspect of diffuse hypercaptive goi...

ea0090ep1040 | Thyroid | ECE2023

Hashitoxicosis : a case report

Hanane Brahimi , Bouchenna Amira , Sara Lamara-Mohamed , Samia Ouldkablia

Introduction: Autoimmune thyroid diseases are frequent and very polymorphic pathologies. The same person can successively present with different manifestations. Graves’ disease and Hashimoto’s thyroiditis seem to be able to coexist. The name "Hashitoxicosis" has been suggested in this case, characterized by the sequential association, whatever the order, of hyper- and hypothyroidism. We report in this work, the case of a patient treated for autoimmune hypothy...

ea0090ep1065 | Thyroid | ECE2023

Diagnosis and management of a thyrotoxicosis storm on unknown hyperthyroidism

Hanane Brahimi , Somia Fetouci , Bouchenna Amira , Samia Ouldkablia

Introduction : In the spectrum of endocrine emergencies, thyroid storm is one of the most critical complications. Recognition and appropriate management of life-threatening thyrotoxicosis is vital to prevent the high morbidity and mortality that may accompany this disorder. The incidence of thyroid storm has been noted to be less than 10% of patients hospitalized for thyrotoxicosis; however, the mortality rate secondary to thyroid storm ranges from 20 to 30%. We report in this...